FBR Capital Remains on Sidelines with Intercept Pharmaceuticals (ICPT) Following FDA Panel Backing

Go back to FBR Capital Remains on Sidelines with Intercept Pharmaceuticals (ICPT) Following FDA Panel Backing
INTERCEPT PHARM (NASDAQ: ICPT) Delayed: 19.00 --0 (-0%)
Previous Close $19.00    52 Week High $186.87 
Open $213.72    52 Week Low $89.76 
Day High $19.00    P/E N/A 
Day Low $19.00    EPS $-5.79 
Volume 2,412,753